Rigel Pharmaceuticals (RIGL) Shares Outstanding (2010 - 2026)

Rigel Pharmaceuticals has reported Shares Outstanding for 17 years, with the latest figure at $18.5 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 3.44% year-over-year to $18.5 million; the trailing twelve-month figure through Mar 2026 stood at $18.5 million (up 3.44% YoY), and the FY2025 full-year result was $18.3 million, up 3.39% from the prior year.
• Shares Outstanding for Q1 2026 stood at $18.5 million, up from $18.3 million in the prior quarter.
• The five-year high for Shares Outstanding was $172.8 million in Q2 2022, with the low at $17.3 million in Q4 2022.
• Average Shares Outstanding over 5 years is $45.1 million, with a median of $17.7 million recorded in 2024.
• Year-over-year, Shares Outstanding plunged 89.91% in 2023 and increased 3.44% in 2026.
• Tracing RIGL's Shares Outstanding over 5 years: stood at $17.3 million in 2022, then advanced by 0.82% to $17.5 million in 2023, then climbed by 1.3% to $17.7 million in 2024, then grew by 3.39% to $18.3 million in 2025, then increased by 0.93% to $18.5 million in 2026.
• The last three Shares Outstanding figures came in at $18.5 million (Q1 2026), $18.3 million (Q4 2025), and $18.1 million (Q3 2025), per Business Quant data.

Peer Comparison